Overview

A Comparison of Dalteparin and Tinzaparin for Prevention of Blood Clots in Hemodialysis Patients on Oral Anticoagulants Having Surgery

Status:
Completed

Trial end date:
2008-11-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to better understand if either dalteparin or tinzaparin is a better drug to use in dialysis patients on blood thinners who are at high risk of developing blood clots and need surgery.

Phase:

Phase 2/Phase 3

Details

Lead Sponsor:

Ottawa Hospital Research Institute

Collaborator:

LEO Pharma

Treatments:

Dalteparin
Heparin, Low-Molecular-Weight
Tinzaparin